(Q34495778)

2 August 2017

1 reference

title

Use of metformin in polycystic ovary syndrome. (English)

1 reference

polycystic ovary syndrome

2 August 2017

main subject

1 reference

1 reference

1 reference

Y De Sloover Koch

1

1 reference

2 August 2017

M E Ernst

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Annals of Pharmacotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

35

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

1644-1647

1 reference

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

2 August 2017

cites work

1 reference

The importance of diagnosing the polycystic ovary syndrome

21 January 2018

1 reference

Insulin action in the normal and polycystic ovary

21 January 2018

1 reference

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.

21 January 2018

1 reference

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

21 January 2018

1 reference

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

21 January 2018

1 reference

Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors

21 January 2018

1 reference

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

21 January 2018

1 reference

Insulin resistance, polycystic ovary syndrome and metformin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A108

1 reference

2 August 2017

1 reference